Eton Pharmaceuticals (ETON) Cash & Equivalents (2017 - 2026)
Eton Pharmaceuticals (ETON) posted Cash & Equivalents of $25.9 million for Q4 2025, down 30.12% sequentially from $37.1 million in Q3 2025, and up 73.69% YoY from $14.9 million in Q4 2024.
Eton Pharmaceuticals (ETON) Cash & Equivalents (2017 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Cash & Equivalents for 9 years, with the latest figure at $25.9 million in Q4 2025.
- Quarterly Cash & Equivalents rose 73.69% year-over-year to $25.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25.9 million (up 73.69% YoY) and the FY2025 annual result came in at $25.9 million, up 73.69% from the prior year.
- Cash & Equivalents eased to $25.9 million in Q4 2025 per ETON's latest filing, from $37.1 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $37.1 million in Q3 2025 and troughed at $13.4 million in Q3 2022.
- A 5-year average of $20.3 million and a median of $19.0 million in 2024 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2021 and 2022: Cash & Equivalents jumped 209.72% in 2021, then plunged 41.09% in 2022.
- Over 5 years, Cash & Equivalents stood at $14.4 million in 2021, then rose by 13.18% to $16.3 million in 2022, then jumped by 31.17% to $21.4 million in 2023, then slumped by 30.17% to $14.9 million in 2024, then soared by 73.69% to $25.9 million in 2025.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $25.9 million, $37.1 million, and $25.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | 26.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.85 Mn |
| Dec 31, 2025 | 25.94 Mn |
| Sep 30, 2025 | 37.12 Mn |
| Jun 30, 2025 | 25.38 Mn |
| Mar 31, 2025 | 17.42 Mn |
| Dec 31, 2024 | 14.94 Mn |
| Sep 30, 2024 | 20.26 Mn |
| Jun 30, 2024 | 17.69 Mn |
| Mar 31, 2024 | 16.66 Mn |
| Dec 31, 2023 | 21.39 Mn |
| Sep 30, 2023 | 22.07 Mn |
| Jun 30, 2023 | 21.57 Mn |
| Mar 31, 2023 | 14.71 Mn |
| Dec 31, 2022 | 16.31 Mn |
| Sep 30, 2022 | 13.38 Mn |
| Jun 30, 2022 | 17.05 Mn |
| Mar 31, 2022 | 15.23 Mn |
| Dec 31, 2021 | 14.41 Mn |
| Sep 30, 2021 | 22.71 Mn |
| Jun 30, 2021 | 25.80 Mn |